Chapter 1. Introduction


1.1. Report description and scope

1.2. Research scope

1.3. Research methodology


1.3.1. Market research process

1.3.2. Market research methodology



Chapter 2. Executive Summary


2.1. Global heparin market, 2017 - 2023 (USD Billion)

2.2. Global heparin market: snapshot



Chapter 3. Heparin Market- Market Dynamics


3.1. Introduction

3.2. Market Drivers


3.2.1. Global heparin market drivers: impact analysis

3.2.2. Increasing treatment of venous thromboembolism

3.3. Market Restraints


3.3.1. Global heparin market restraints: impact analysis

3.3.2. Significant side effects of the porcine heparin are likely to limit the market growth

3.4. Opportunities


3.4.1. Increasing unmet medical needs in developing countries

3.5. Porters five forces analysis


3.5.1. Bargaining power of suppliers

3.5.2. Bargaining power of buyers

3.5.3. The threat of new entrants

3.5.4. The threat of new substitutes

3.5.5. Degree of competition

3.6. Market Attractiveness Analysis


3.6.1. Market attractiveness analysis, by product type segment

3.6.2. Market attractiveness analysis, by source type segment

3.6.3. Market attractiveness analysis, by type of formulation segment

3.6.4. Market attractiveness analysis, by regional segment



Chapter 4. Global Heparin Market- Competitive Landscape


4.1. Company market share analysis


4.1.1. Global heparin market: company market share, 2017

4.2. Strategic development


4.2.1. Acquisitions mergers

4.2.2. New therapy launch

4.2.3. Agreements, partnerships, collaborations and joint ventures

4.2.4. Research and development and regional expansion

4.3. Price trend analysis



Chapter 5. Global Heparin Market- Product Type Segment Analysis


5.1. Global heparin market: product overview


5.1.1. Global heparin market revenue share, by product type, 2017 and 2023

5.2. Unfractionated Heparin (UFH)


5.2.1. Global heparin market for unfractionated heparin market, 2017 - 2023 (USD Billion)

5.3. Low Molecular Weight Heparin (LMWH)


5.3.1. Global heparin market for low molecular weight heparin market, 2017 - 2023 (USD Billion)

5.4. Ultra-low Molecular Weight Heparin (ULMWH)


5.4.1. Global heparin market for ultra-low molecular weight heparin market, 2017 - 2023 (USD Billion)



Chapter 6. Global Heparin Market- Source Type Segment Analysis


6.1. Global heparin market: form type overview


6.1.1. Global heparin market revenue share, by source type, 2017 and 2023

6.2. Bovine


6.2.1. Global heparin market for bovine, 2017 - 2023 (USD Billion)

6.3. Porcine


6.3.1. Global heparin market for porcine, 2017 - 2023 (USD Billion)



Chapter 7. Global Heparin Market- Type of Formulation Segment Analysis


7.1. Global heparin market: type of formulation overview


7.1.1. Global heparin market revenue share, by type of formulation, 2017 and 2023

7.2. Oral


7.2.1. Global heparin market for oral, 2017 - 2023 (USD Billion)

7.3. Parental


7.3.1. Global heparin market for parental 2017 - 2023 (USD Billion)



Chapter 8. Global Heparin Market- Regional Segment Analysis


8.1. Global heparin market: regional overview


8.1.1. Global heparin market revenue share, by region, 2017 and 2023

8.2. North America


8.2.1. North America heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.2.2. North America heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.2.3. North America heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.2.4. U.S.


8.2.4.1. U.S. heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.2.4.2. U.S. heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.2.4.3. U.S. heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.2.5. Canada


8.2.5.1. Canada heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.2.5.2. Canada heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.2.5.3. Canada heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.2.6. Rest of North America


8.2.6.1. Rest of North America heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.2.6.2. Rest of North America heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.2.6.3. Rest of North America heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.3. Europe


8.3.1. Europe heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.3.2. Europe heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.3.3. Europe heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.3.4. U.K.


8.3.4.1. U.K. heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.3.4.2. U.K. heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.3.4.3. U.K. heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.3.5. Germany


8.3.5.1. Germany heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.3.5.2. Germany heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.3.5.3. Germany heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.3.6. France


8.3.6.1. France heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.3.6.2. France heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.3.6.3. France heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.3.7. Italy


8.3.7.1. Italy heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.3.7.2. Italy heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.3.7.3. Italy heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.3.8. Spain


8.3.8.1. Spain heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.3.8.2. Spain heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.3.8.3. Spain heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.3.9. Russia


8.3.9.1. Russia heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.3.9.2. Russia heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.3.9.3. Russia heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.3.10. Rest of Europe


8.3.10.1. Rest of Europe heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.3.10.2. Rest of Europe heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.3.10.3. Rest of Europe heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.4. Asia Pacific


8.4.1. Asia Pacific heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.4.2. Asia Pacific heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.4.3. Asia Pacific heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.4.4. China


8.4.4.1. China heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.4.4.2. China heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.4.4.3. China heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.4.5. Japan


8.4.5.1. Japan heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.4.5.2. Japan heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.4.5.3. Japan heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.4.6. India


8.4.6.1. India heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.4.6.2. India heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.4.6.3. India heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.4.7. Australia


8.4.7.1. Australia heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.4.7.2. Australia heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.4.7.3. Australia heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)



8.4.8. Rest of Asia Pacific


8.4.8.1. Rest of Asia Pacific heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.4.8.2. Rest of Asia Pacific heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.4.8.3. Rest of Asia Pacific heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.5. Latin America


8.5.1. Latin America heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.5.2. Latin America heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.5.3. Latin America heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.5.4. Brazil


8.5.4.1. Brazil heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.5.4.2. Brazil heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.5.4.3. Brazil heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.5.5. Mexico


8.5.5.1. Mexico heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.5.5.2. Mexico heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.5.5.3. Mexico heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.5.6. Argentina


8.5.6.1. Argentina heparin market revenue, by product type, 2017 - 2023 (USD Billion)



8.5.6.2. Argentina heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.5.6.3. Argentina heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.5.7. Rest of Latin America


8.5.7.1. Rest of Latin America heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.5.7.2. Rest of Latin America heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.5.7.3. Rest of Latin America heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.6. Middle East and Africa


8.6.1. Middle East and Africa heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.6.2. Middle East and Africa heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.6.3. Middle East and Africa heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.6.4. Saudi Arabia


8.6.4.1. Saudi Arabia heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.6.4.2. Saudi Arabia heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.6.4.3. Saudi Arabia heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.6.5. UAE


8.6.5.1. UAE heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.6.5.2. UAE heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.6.5.3. UAE heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.6.6. Qatar


8.6.6.1. Qatar heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.6.6.2. Qatar heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.6.6.3. Qatar heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.6.7. South Africa


8.6.7.1. South Africa heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.6.7.2. South Africa heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.6.7.3. South Africa heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)

8.6.8. Rest of Middle East and Africa


8.6.8.1. Rest of Middle East and Africa heparin market revenue, by product type, 2017 - 2023 (USD Billion)

8.6.8.2. Rest of Middle East and Africa heparin market revenue, by source type, 2017 - 2023 (USD Billion)

8.6.8.3. Rest of Middle East and Africa heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)



Chapter 9. Company Profile


9.1. Dr. Reddys Laboratories Ltd.


9.1.1. Overview

9.1.2. Financials

9.1.3. Therapy portfolio

9.1.4. Business strategy

9.1.5. Recent developments

9.2. Teva Pharmaceutical Industries Ltd.


9.2.1. Overview

9.2.2. Financials

9.2.3. Therapy portfolio

9.2.4. Business strategy

9.2.5. Recent developments

9.3. Fresenius SE Co. KGaA


9.3.1. Overview

9.3.2. Financials

9.3.3. Therapy portfolio

9.3.4. Business strategy

9.3.5. Recent developments

9.4. Sanofi


9.4.1. Overview

9.4.2. Financials

9.4.3. Therapy portfolio

9.4.4. Business strategy

9.4.5. Recent developments

9.5. Pfizer, Inc.


9.5.1. Overview

9.5.2. Financials

9.5.3. Therapy portfolio

9.5.4. Business strategy

9.5.5. Recent developments

9.6. LEO Pharma A/S


9.6.1. Overview

9.6.2. Financials

9.6.3. Therapy portfolio

9.6.4. Business strategy

9.6.5. Recent developments

9.7. Aspen


9.7.1. Overview

9.7.2. Financials

9.7.3. Therapy portfolio

9.7.4. Business strategy

9.7.5. Recent developments

9.8. Baxter International, Inc.


9.8.1. Overview

9.8.2. Financials

9.8.3. Therapy portfolio

9.8.4. Business strategy

9.8.5. Recent developments

9.9. Syntex S.A.


9.9.1. Overview

9.9.2. Financials

9.9.3. Therapy portfolio

9.9.4. Business strategy

9.9.5. Recent developments